Drug therapies for mesenteric vascular disease

Heart Disease

Volumn 4, Issue 5, 2002, Pages 306-314

  Tabriziani, Hossein ^a   Shieu, Aileen ^a   Frishman, William H ^a   Brandt, Lawrence J ^a  

^a MONTEFIORE MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOPURINOL; AMINOCAPROIC ACID; ANTIBIOTIC AGENT; ANTICOAGULANT AGENT; ANTIHISTAMINIC AGENT; CORTICOSTEROID; CORTICOTROPIN RELEASING FACTOR; DOPAMINE; FIBRINOLYTIC AGENT; FREE RADICAL; GASTRIC INHIBITORY POLYPEPTIDE; HEPARIN; INFUSION FLUID; ISOPRENALINE; PAPAVERINE; PARACETAMOL; PROSTACYCLIN; PROSTAGLANDIN D2; PROSTAGLANDIN E1; PROTEINASE INHIBITOR; SCAVENGER; STEROID; STREPTOKINASE; SUPEROXIDE DISMUTASE; TEPROTIDE; TOLAZOLINE; UNINDEXED DRUG; UROKINASE; VASODILATOR AGENT; WARFARIN;

ACUTE MESENTERIC ISCHEMIA; ALLERGIC REACTION; ARTERY CATHETERIZATION; BLEEDING; BLOOD CLOTTING DISORDER; CHRONIC MESENTERIC ISCHEMIA; CLINICAL TRIAL; COLON ISCHEMIA; EMBOLISM; ERYTHROCYTE DISORDER; FEVER; HUMAN; ISCHEMIA; MESENTERIC VASCULAR DISEASE; MESENTERY BLOOD VESSEL; MUSCLE NECROSIS; MYOPATHY; NONHUMAN; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; THROMBOSIS; VASCULAR DISEASE; VASCULITIS;

EID: 0036746144     PISSN: 1521737X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00132580-200209000-00007     Document Type: Review

References (108)

1. Char D, Hines G. Chronic mesenteric ischemia. Diagnosis and treatment. Heart Disease 2001;3:231-235.
2. American Gastroenterological Association. AGA technical review on intestinal ischemia. Gastroenterol 2000;118:954-968.
3. Brandt LJ. Ischemic bowel: How often is it misdiagnosed? In: Barkin J, Rogers A (eds). Difficult Decisions in Digestive Diseases. Chicago: Year Book Medical Publishers, 1989:359-361.
4. Abbot WM, Maloney RD, McCabe CC, et al. Arterial embolism: A 44 year perspective. Am J Surg 1982;143:460-464.
5. Batellier J, Kieny R. Superior mesenteric artery embolism: Eighty-two cases. Ann Vase Surg 1990;4:112-116.
6. Freischlag JA, Towne JB. Mesenteric ischemia. In: Haimovici H, Ascer E, Hollier LH, et al (eds). Vascular Surgery. 4th ed. Cambridge, MA: Blackwell Science, 1996:996-1007.
7. Bakal CW, Sprayregen S, Wolf EL. Radiology in intestinal ischemia: Angiographic diagnosis and management. Surg Clin North Am 1992;72:125-141.
8. Cohn I, Floyd CE, Dresde F, et al. Strangulation obstruction in germ free animals. Ann Surg 1962;156:692.
9. Boley SJ, Sprayregen S, Siegelman SS, Veith FJ. Initial results from an aggressive roentgenological and surgical approach to acute mesenteric ischemia. Surgery 1977;82:848-855.
10. Clark RA, Gallant TE. Acute mesenteric ischemia: angiographic spectrum. Am J Roentgenol 1984;142:555-562.
11. O'Mara CS, Ernst CB. Acute mesenteric ischemia. In: Zuidema GD, Nyhus LM (eds). Shackelford's Surgery of the Alimentary Tract. 4th ed. Philadelphia: WB Saunders, 1996:17-32.
12. Rivers SP, Veith FJ. Nonocclusive mesenteric ischemia. In: Rutherford RB (ed). Vascular Surgery. 4th ed. Philadelphia: WB Saunders, 1995:1284-1288.
13. Kukovetz WR, Poch G. Inhibition of cyclic 3′,5′ nucleotide-phosphodiesterase as a possible mode of action of papaverine and similarly acting drugs. Naunyn Schmiede Arch Pharmacol 1970;267:189-194.
14. Hunter GC, Guernsey JM. Mesenteric ischemia. Med Clin North Am 1988;72:1091-1115.
15. Boley SJ, Feinstein FR, Sammartano R, et al. New concepts in the management of emboli of the superior mesenteric artery. Surg Gynecol Obstet 1981;153:561-569.
16. Williams RA, Wilson SE. Effect of intraarterial vasodilators on blood flow in ischemic dog colon. Arch Surg 1980;115:602-605.
17. Kaleya RN, Sammartano RJ, Boley SJ. An aggressive approach to acute mesenteric ischemia. Surg Clin North Am 1992;72:157-182.
18. McKinsey JF, Gewertz BL. Acute mesenteric ischemia. Surg Clin North Am 1997;77:307-318.
19. Pai SM, Torres V. Atrial fibrillation: New management strategies. Curr Probl Cardiol 1993;18:235-300.
20. Hylek EM, Skates SJ, Sheehan MA, et al. An analysis of the lowest effective intensity of prophylactic anticoagulation for patients with nonrheumatic atrial fibrillation. N Engl J Med 1996;335:540-546.
21. Schocnbaum SW, Pena C, Koenigsberg P, Katzen BT. Superior mesenteric artery embolism: treatment with intraarterial urokinase. J Vase Interv Radiol 1992;3:485-490.
22. Vujic I, Stanley J, Gobien R. Treatment of an acute embolus of the SMA by topical infusion of streptokinase. Cardiovasc Interv Radiol 1984;7:94-96.
23. McBride KD, Gaines PA. Thrombolysis of a partially occluding superior mesenteric artery thromboembolism by infusion of streptokinase. Cardiovasc Interv Radiol 1994;17:164-166.
24. Regan F, Karlstad RR, Magnuson TH. Minimally invasive management of acute superior mesenteric artery occlusion: combined urokinase and laparoscopic therapy. Am J Gastroenterol 1996;91:1019-1021.
25. Simo G, Echenagusia AJ, Camunez F. et al. Superior mesenteric embolism: local fibrinolytic treatment with urokinase. Radiology 1997;204:775-779.
26. Yamaguchi T, Saeki M, Iwasaki Y, et al. Local thrombolytic therapy for superior mesenteric artery embolism: complications and long-term clinical follow up. Rad Med 1999;17:27-33.
27. Bell WR, Meek AG. Guidelines for the use of thrombolytic agents. N Engl J Med 1979;301:1266-1270.
28. Majerus PW, Broze GJ, Miletich JP, et al. Anticoagulant, thrombolytic, and antiplatelet drugs. In: Hardman JG, Goodman, Gilman A. Limbird LE (eds). The Pharmacological Basis of Therapeutics. 9th ed. New York: McGraw Hill, 2000:1341-1358.
29. Van Deinse WH, Zawacki JK, Phillips D. Treatment of acute mesenteric ischemia by percutaneous transluminal angioplasty. Gastroenterol 1986;91:475-478.
30. Kaleya RN, Boley SJ. Acute mesenteric vascular disease. In: Veith FJ, Hobson RW II, Williams RA, et al (eds). Vascular Surgery: Principles and Practice, 2nd ed. New York: McGraw-Hill, 1994:762-780.
31. Wilson C, Gupta R, Gilmour DG, et al. Acute superior mesenteric ischaemia. Br J Surg 1987;74:279-281.
32. Niederhauser U, Genoni M, von Segesser LK, et al. Mesenteric ischemia after a cardiac operation: conservative treatment with local vasodilation. Ann Thorac Surg 1996;61:1817-1819.
33. Eker A, Malzac B, Teboul J, Jourdan J. Mesenteric ischemia after coronary artery bypass grafting: should local continuous intra-arterial perfusion with papaverine be regarded as a treatment? Eur J Cardiothorac Surg 1999;15:218-220.
34. Hung KH, Lee CT, Lam KK, et al. Ischemic bowel disease in chronic dialysis patients. Chang Keng I Hsueh Tsa Chih 1999;22:82-87.
35. Bailey RW, Bulkely GB, Hamilton SR, et al. Protection of the small intestine from nonocclusive mesenteric ischemic injury due to cardiogenic shock. Am J Surg 1987;153:108-116.
36. Parks DA, Bulkley GB, Granger DN, et al. Ischemic injury in the cat small intestine: role of superoxide radicals. Gastroenterol 1982;82:9-15.
37. Granger DN, McCord JM, Parks DA, Hollwarth ME. Xanthine oxidase inhibitors attenuate ischemia-induced vascular permeability changes in the cat intestine. Gastroenterol 1986;90:80-84.
38. Vohra K. Rosenfeld W, Singh I, Anderson V. Ischemic injury to newborn rabbit ileum: protective role of human superoxide dismutase. J Ped Surg 1989;24:893-898.
39. Demetriou AA, Kagoma PK, Kaiser S, et al. Effect of dimethyl sulfoxide and glycerol on acute bowel ischcmia in the rat. Am J Surg 1985;149:91-94.
40. Zimmerman BJ, Granger DN. Reperfusion injury. Surg Clin North Am 1992;72:65-83.
41. Ulano HB, Treat E, Shanbour LL, Jacobson ED. Selective dilation of the constricted superior mesenteric artery. Gastroenterol 1972;62:39-47.
42. Davis LJ, Anderson J, Wallace S, Jacobson ED. Experimental use of prostaglandin E1 in non-occlusive mesenteric ischemia. Am J Roentgenol Radium Ther Nucl Med 1975;125:99-110.
43. Fondacaro JD, Walus KM, Schwaiger M, et al. Vasodilation of the normal and ischemic canine mesenteric circulation. Gerstroenterol 1981;80:1542-1549.
44. Schwaiger M, Fondacaro JD, Jacobson ED. Effects of glucagon, histamine and perhexiline on the ischemic canine mesenteric circulation. Gastroenterol 1979;77:730-735.
45. Lanciault G, Fang WF, Jacobson ED, et al. Evaluation of potential agents for treatment of nonocclusive mesenteric ischemia in the dog. Circ Shock 1976;3:239.
46. Bond JH, Levitt MD. Effect of glucagon on gastrointestinal blood flow of dogs in hypovolemic shock. Am J Physiol 1980;238:434-439.
47. Kogire M, Inoue K, Sumi S, et al. Effects of synthetic human gastric inhibitory polypeptide on splanchnic circulation in dogs. Gastroenterol 1988;95:1636-1640.
48. MacCannell KL, Newton CA, Lederis K, et al. Use of selective mesenteric vasodilator peptides in experimental nonocclusive mesenteric ischemia in the dog. Gastroenterol 1986;90:669-676.
49. Bounous G, Hampson LG, Gurd FN. Cellular nucleotides in hemorrhagic shock: relationship of intestinal metabolic changes to hemorrhagic enteritis and the barrier function of intestinal mucosa. Ann Surg 1964;160:650.
50. Bounous G, Brown RA, Mulder DS, et al. Abolition of tryptic enteritis in the shocked dog. Arch Surg 1965;91:371.
51. Bounous G. Pancreatic proteases and oxygen-derived free radicals in acute ischemic enteropathy. Surgery 1986;99:92.
52. Oldham KT, Guice KS, Gore D, et al. Treatment of intestinal ischemia with oxygenated intraluminal perfluorocarbons. Am J Surg 1987;153:291-294.
53. Ricci JL, Sloviter HA, Ziegler MM. Intestinal ischemia: reduction of mortality utilizing intraluminal perfluorochemicals. Am J Surg 1985;149:84-90.
54. Daniel WJ, Mohamed SD, Matheson NA. Treatment of mesenteric embolism with dextran 40. Lancet 1966;12:567-569.
55. Boley SJ, Kaleya RN, Brandt LJ. Mesenteric vcnous thrombosis. Surg Clin North Am 1992;72:183-201.
56. Kairaluoma MI, Karkola P, Heikkinen E, et al. Mesenteric infarction. Am J Surg 1977;133:188-193.
57. Moriau M, Zzerad MA. Importance of medical treatment in mesenteric vein thrombosis (MVT). Acta Gastroenterol Belg 1996;59:146-149.
58. Rhee RY, Gloviczki P, Mendonca CT, et al. Mesenteric venous thrombosis: still a lethal disease in the 1990s. J Vasc Surg 1994;20:688-697.
59. Elliot JW. The operative relief of gangrene of intestine due to occlusion of the mesenteric vessels. Ann Surg 1895;21:9-23.
60. Cokkinis AJ. Mesenteric Vascular Occlusion. Balliete: Tindall and Cox, 1926:1-93.
61. Warren S, Eberhard TP. Mesenteric venous thrombosis. Surg Gynecol Obstet 1935;141:740-742.
62. Bilbao JI, Rodriguez-Cabello J, Longo J, et al. Portal thrombosis: percutaneous transhepatic treatment with urokinase - a case report. Gastrointest Radiol 1989;14:326-329.
63. Karawi MA, Guaiz M, Clark D, et al. Mesenteric vein thrombosis, noninvasive diagnosis and follow up (US + MRI) and noninvasive therapy by streptokinase and anticoagulants. Hepatogastroenterol 1990;37:507-509.
64. Rivitz SM, Geller SC, Hahn C, et al. Treatment of acute mesenteric venous thrombosis with transjugular intramesenteric urokinase infusion. J Vasc Intervent Radiol 1995;6:219-223.
65. Train JS, Ross H, Weiss JD, et al. Mesenteric venous thrombosis: successful treatment by intraarterial lytic therapy. J Vasc Interv Radiol 1998;9:461-464.
66. Ludwig DJ, Hauptmann E, Rosoff L Jr, Neuzil D. Mesenteric and portal vein thrombosis in a young patient with protein S deficiency treated with urokinase via the superior mesenteric artery. J Vasc Surg 1999;30:551-554.
67. Poplausky MR, Kaufman JA, Geller SC, Waltman AC. Mesenteric venous thrombosis treated with urokinase via the superior mesenteric artery. Gastroenterol 1996;110:1633-1635.
68. Sehgal M, Haskal ZJ. Use of transjugular intrahepatic portosystemic shunts during lytic therapy of extensive portal splenic and mesenteric venous thrombosis: long-term follow up. J Vasc Interv Radiol 2000;11:61-65.
69. Lau LL, McMurray AH. Mesenteric venous thrombosis in protein S deficiency: case report and literature review. Ulster Med 1999;68:33-35.
70. Rhee RY, Gloviczki P. Mesenteric vein thrombosis. Surg Clin North Am 1997;77:327-338.
71. Kaleya RN, Boley SJ. Mesenteric venous thrombosis. In: Najarian JS, Delaney JP (eds). Progress in Gastrointestinal Surgery. Chicago: Yearbook Medical, 1989:417-425.
72. Cunningham CG, Reilly LM, Stoney R. Chronic visceral ischemia. Surg Clin North Am 1992;72:231-244.
73. Rogers AI, David S. Intestinal blood flow and diseases of vascular impairment. In: Haubrich WS, Schaffner F, Berk JE (eds). Bockus: Gastroenterology. 5th ed. Philadelphia, WB Saunders, 1995:1212-1234.
74. Brandt LJ, Boley SJ. Ischemic and vascular lesions of the bowel. In: Sleisenger MH, Fordtran JS (eds). Gastrointestinal Disease. 4th ed. Philadelphia: WB Saunders, 1989:1927-1961.
75. Maspes F, Mazzetti G, Gandini R, et al. Percutaneous transluminal angioplasty in the treatment of chronic mesenteric ischemia: results and 3 years of follow-up in 23 patients. Abdom Imaging 1998;23:358-363.
76. McShane MD, Proctor A, Spencer P, et al. Mesenteric angioplasty for chronic intestinal ischaemia. Eur J Vasc Surg 1992;6:333-336.
77. Tegtmeyer CJ, Selby JB. Balloon angioplasty of the visceral arteries (renal and mesenteric circulation): indications, results, and complications. In: Monge WS, Ahn SS (eds). Endovascular Surgery. Philadelphia: WB Saunders, 1989:223-257.
78. Taylor DC, Houston TM, Anderson C, et al. Follow-up of renal and mesenteric artery revascularization with duplex ultrasonography. Can J Surg 1996;39:17-20.
79. Hackworth CA, Leef JA. Percutaneous transluminal mesenteric angioplasty. Surg Clin North Am 1997;77:371-380.
80. Rose SC, Quigley TM, Raker EJ. Revascularization for chronic mesenteric ischemia: comparison of operative arterial bypass grafting and percutaneous transluminal angioplasty. J Vasc Intervent Radiol 1995;6:339-349.
81. Mavrelis PG, Doumanian H. Pentoxifylline for mesenteric ischemia (letter). Am J Gastroenterol 1987;82:175.
82. Sarnoff SI, Fine J. Effect of chemotherapy on ileum subjected to vascular injury. Ann Surg 1945;121:74.
83. Poth EJ, McClure JN Jr. Intestinal obstruction: protective action of sulfasuxidine and sulfathalidine to ileum following vascular damage. Ann Surg 1950;131:159.
84. Tedesco FJ, Volpicelli NA, Moore FS. Estrogen and progesterone-associated colitis: a disorder with clinical and endoscopic features mimicking Crohn's colitis. Gastrointest Endosc 1982;28:247-249.
85. Hassan HA. Oral contraceptive-induced mesenteric venous thrombosis with resultant intestinal ischemia. J Clin Gastroenterol 1999;29:90-95.
86. Schmitt W, Wagner-Thiessen E, Lux G. Ischaemic colitis in a patient treated with glypressin for bleeding oesophageal varices. Hepatogastroenterol 1987;34:134-136.
87. Gollock JM, Thomson JP. Ischaemic colitis associated with psychotropic drugs. Postgrad Med 1984;60:564-565.
88. Fishel R, Hamamoto G, Barbul A, et al. Cocaine colitis: is this a new syndrome? Dis Col Rect 1985;28:264-266.
89. Johnson TD, Berenson MM. Methamphetamine-induced ischemic colitis. J Clin Gastroenterol 1991;13:687-689.
90. Wright A, Benfield GF, Felix-Davies D. Ischaemic colitis and immune complexes during gold therapy for rheumatoid arthritis. Ann Rheum Dis 1984;43:495-497.
91. Dabney JM, Scott JB, Chou CC. Effects of cations on ileal compliance and blood flow. Am J Physiol 1967;212:835-839.
92. Allen A, Boley S, Schultz L, et al. Potassium induced lesions of the small bowel. JAMA 1965;193:997.
93. Zizic TM, Classen JN, Stevens MB. Acute abdominal complications of systemic lupus erythematosus and polyarteritis nodosa. Am J Med 1982;73:525-531.
94. Wold L, Baggenstoss A. Gastrointestinal lesions of polyarteritis nodosa. Mayo Clin Proc 1949;24:28.
95. Scott DG, Bacon PA, Tribe CR. Systemic rheumatoid vasculitis: a clinical and laboratory study of 50 cases. Medicine 1981;60:288-297.
96. Burt RW, Berenson MM, Samuelson CO, et al. Rheumatoid vasculitis of the colon presenting as pancolitis. Dig Sic Sci 1983;28:183-188.
97. Engesser L, Broekmans AQ, Briet E, et al. Hereditary protein S deficiency. Clinical manifestations. Ann Intern Med 1987;106:677-682.
98. Broekmans AW. Hereditary protein C deficiency. Haemostasis 1985;15:233-240.
99. Orozco H, Guraieb E, Takahashi T, et al. Deficiency of protein C in patients with portal vein thrombosis. Hepatology 1988;8:1110-1111.
100. Cosgriff TM, Bishop DT, Hershgold EJ, et al. Familial antithrombin III deficiency: its natural history, genetics, diagnosis and treatment. Medicine 1983;62:209-220.
101. Maung R, Kelly JK, Schneider MP, et al. Mesenteric venous thrombosis due to anti-thrombin III deficiency. Arch Pathol Lab Med 1988;112:37-39.
102. Stern JM, Saver JL, Boldy RM, DeGregorio F. Homocysteine associated hyper-coagulability and disseminated thrombosis - a case report. Angiology 1998;49:765-769.
103. Bergenfeldt M, Svensson PJ, Borgstrom A. Mesenteric vein thrombosis due to factor V Leiden gene mutation. Br J Surg 1999;86:1059-1062.
104. Heresbach D, Pagenault M, Gueret P, et al. Leiden factory V mutation in Four patients with small bowel infarctions. Gastroenterol 1997;113:322-325.
105. Marie I, Levesque H, Lecam-Duchez V, et al. Mesenteric venous thrombosis revealing both factor II G20212A mutation and hyperhomocysteinemia related to pernicious anemia. Gastroenterol 2000;118:237-238.
106. Seeburger JL, Stepak M, Fukuchi SG, et al. Multiple arterial thromboembolisms in a patient with a 20210A prothrombin gene mutation. Arch Surg 2000;135:721-722.
107. Zuazu-Jausoro I, Sanchez I, Fernandez MC, et al. Portal and mesenteric venous thrombosis in a patient heterozygous for the 20210A allele of the prothrombin gene. Haematologica 1998;83:1129-1130.
108. Gage TP, Gagnier JM. Ischemic colitis complicating sickle cell crisis. Gastroenterol 1983;84:171-174.